Case Study

Infusion care without the road trip

mR9lyeUd HefA5OO Fatherandsonphoto 4962%C3%972439 father and son 4962x2439 1 image

The challenge

Dave lives in a rural area of the Pacific Northwest and was diagnosed with gout. His care team prescribed Krystexxa, an infusion therapy administered every two weeks.

Dave’s only treatment option required driving more than four hours round trip to a hospital system every other week. The travel time and disruption quickly became unsustainable, both personally and financially, making it difficult to stay on track with treatment.

dqJsm3DC0lf3fvwr MeetDavememberstory%E2%80%94high resolutionexports leap member card dave 4962x2439 image

The Leap solution

Seeking a more accessible option, Dave was referred to Leap through a large employer TPA.

A Leap Care Guide partnered with Dave, his prescribing physician, and the employer TPA to coordinate in-home infusion care. Within one week:
• Dave’s first Krystexxa infusion was scheduled and delivered at home
• A licensed infusion nurse was assigned
• Ongoing infusions were scheduled every two weeks to support adherence

Patient impact

By eliminating the need to travel, Leap made it easier for Dave to stay consistent with treatment while minimizing disruption to his daily life and family time.

e8x4USQ7SeObE4Hm Davememberquote%E2%80%94fatherandsonongrass 4962%C3%972439%2C300PPI employer roi member quote grass 4962x2439 image

Employer impact

By avoiding hospital-based infusion care and supporting treatment adherence through home infusion, Leap Health helped Dave’s employer realize $711,000 in claims-validated annual savings.

KlarZ2n0t1JXjeHj EmployerROI%E2%80%94Employerimpactalternatesplitlayout 4962%C3%972439%2C300PPI employer roi employer impact layout alternate 4962x2439 image

The patient experience drives employer outcomes

Better patient experiences and stronger employer outcomes are correlated. Patients who stay engaged with a Care Guide are more likely to complete treatment and manage their condition, and that shows up on the employer side as:

  • Claims savings
  • Steadier attendance
  • Fewer benefits questions landing on HR’s desk

More than 45% of total member engagement comes from personalized Care Guide support, saving members close to 3 hours per treatment they would otherwise spend chasing authorizations and sitting in waiting rooms.

Check out our blog post to learn more about the value of the patient experience. 

Additional impact stories

Dave’s story is unique, but he is one of many patients who have benefitted from Leap. Check out some other patient stories by clicking either of the tiles below. 

Share this post

More insights

uGsQNuRFuKAhTzKX benefits leader a reviewing report image
Education

Your guide to J-codes in medical billing, and what they can hide

An employer’s specialty trend was running at double digits, driven largely by therapies like Ocrevus...

Read article
gr 7yJaj1xLjiPDQ inside nurseadjustingIVdripforseniorpatientathome image
Education

Want to increase member participation in a specialty medicine solution? Reducing or waiving cost share is a good start.

One employee at a self-funded employer received Gammagard infusions twice a month for a rare autoimm...

Read article
A2LILi0roy6lnpj7 task export 6 image
Education

6 specialty medicine trends for 2027 and what they mean for benefits leaders

If it feels like specialty medicine is changing faster than your benefits strategy can keep up, that...

Read article
qmQqiddpjKSpw85s HRprofessional%E2%80%94intheoffice hr professional 3 office image
Education

Healthcare point solutions: What they are and 5 questions when evaluating them

If every healthcare point solution delivered the return in its sales deck, employer health costs wou...

Read article
XC0BuEWYGds6rfBI WeInfusepartnershipbloggraphic PNG%2C4962%C3%972439%2C300PPI 1 image
News

Leap expands specialty infusion network with WeInfuse collaboration

Leap is expanding its employer specialty infusion network through a new collaboration with WeInfuse,...

Read article
mIVvKbrIeVcspajE Spring Fall couplesittingtogetherongardenbenchwithcoffee image
Insights

Infusion vs. injection: Breaking down the basics of these two specialty therapies

In 1995, there were about 30 specialty drugs on the market. Today, there are nearly 1,000, and rough...

Read article
EJGfZMLy5m1bnieu inside closeupivdripformingdropletinhospital image
Insights

Let's blow up the buy-and-bill drug model: How it works and what it costs employers

Twice a year, a member with multiple sclerosis (MS) sits down for an Ocrevus infusion. The drug is t...

Read article
aVrzVnNYClf9oxJK Leap MS image
Insights

The real cost of MS infusion therapy and how a better member experience can bring down costs

For two years, Maria drove two hours each way for her multiple sclerosis (MS) treatment. Every appoi...

Read article
Oncology biosimilars market
Education

The emerging oncology biosimilars market and how employers can prepare.

A member who starts Keytruda today will likely organize the next two years of their life around it. ...

Read article
WWqCZQJnAGmcLNW4 Summer couplesittingtogetheronporchswing image
Education

Is home infusion safe for immunoglobulin therapy? What patients should know

Whether you've just been prescribed immunoglobulin (Ig) therapy, or you've been getting it at a clin...

Read article